Table 4.
Comparison of Demographic, Clinical, Hematological and Virological Markers Parameters Among Patients with Acute Myeloid Leukemia after Chemotherapy Induction According to Presence of Parvovirus B19 Infection.
| Parameter | Recent Infection | Past Infection group | p value |
|---|---|---|---|
| (n=11) | (n=4) | ||
| Sex | |||
| Male | 8 (72.2%) | 3 (75%) | 0.1 |
| Female | 3 (36.4%) | 1 (25%) | |
| Age | 6.5±3.7 | 5.8±3.7 | 0.9 |
| Rash | 7 (63.7%) | 0 (0%) | 0.02 |
| Fever | 4 (36.4%) | 0 (0%) | 0.3 |
| Hepatosplenomegaly | 4 (36.4%) | 0 (0%) | 0.3 |
| Lymphadenopathy | 3 (27.3%) | 4 (100%) | 0.02 |
| Hemoglobin g/dl | 10.2±0.6 | 11.5±4.00 | 0.03 |
| RBCs x 106/l | 3.45±0.2 | 3.5±1.0 | 0.2 |
| WBCs x 103/mm3 | 12.0±1.4 | 29.00±4.00 | 0.1 |
| Lymphocytes x 103/mm3 | 9.450±1.20 | 25.0±10.0 | 0.03 |
| Neutrophils x 103/mm3 | 1.2±1.0 | 2.9±1.5 | 0.005 |
| Platelets x 103/mm3 | 54.5±28.6 | 168.4±4.00 | 0.0001 |
| IgM | 8 (72.7%) | 0 (0%) | 0.04 |
| PCR | 8 (72.7%) | 0 (0%) | 0.04 |
| IgG | 4 (36.4%) | 4 (100%) | 0.7 |